Subject to subsections (b) and (c) of this section, the Program shall provide remote ultrasound procedures and remote fetal nonstress tests using current procedural terminology codes if: The patient is in a residence or a location other than the office of the patient’s provider; and The provider follows the same standard of care that the provider would follow when providing the services on–site. The Program shall require that a provider offering a remote ultrasound procedure or remote fetal nonstress test use digital technology: To collect any health data from the patient and electronically transmit the information in a secure manner to a health care provider in a different location for interpretation and recommendations; That is compliant with the federal Health Insurance Portability and Accountability Act of 1996; and That is approved by the federal Food and Drug Administration. The Program shall provide reimbursement for a remote fetal nonstress test in the same manner as an on–site fetal nonstress test. A remote fetal nonstress test for which reimbursement is provided under paragraph (1) of this subsection shall require the use of remote monitoring solutions that are cleared by the federal Food and Drug Administration for on–label use for monitoring: Fetal heart rate; Maternal heart rate; and Uterine activity. The Program shall issue guidance for Program providers to carry out this section.